Cargando…
Comparison of adverse events between intravitreal anti-VEGF and laser photocoagulation for treatment-requiring retinopathy of prematurity: a systematic review
PURPOSE: To synthesize existing evidence on adverse events, complications, and unfavorable outcomes of current treatment modalities for treatment-requiring retinopathy of prematurity (TR-ROP). METHODS: PubMed, Cochrane Central Register of Controlled Trials, Scopus, EMBASE, Trip Database, and the gra...
Autores principales: | Tsiropoulos, Georgios N., Seliniotaki, Aikaterini K., Haidich, Anna-Bettina, Ziakas, Nikolaos, Mataftsi, Asimina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042936/ https://www.ncbi.nlm.nih.gov/pubmed/36214992 http://dx.doi.org/10.1007/s10792-022-02480-6 |
Ejemplares similares
-
Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial
por: Seliniotaki, Aikaterini K., et al.
Publicado: (2022) -
Comment on the Article: Choroidal Thickness in Pediatric Populations
por: Prousali, Efthymia, et al.
Publicado: (2021) -
Comparison of Intravitreal Anti-VEGF Agents With Laser Photocoagulation for Retinopathy of Prematurity of 1,627 Eyes in China
por: Linghu, Dandan, et al.
Publicado: (2022) -
Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012) -
Combination therapy of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity
por: Dudani, Ajay I, et al.
Publicado: (2022)